BR112014019504A2 - alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune - Google Patents

alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune

Info

Publication number
BR112014019504A2
BR112014019504A2 BR112014019504A BR112014019504A BR112014019504A2 BR 112014019504 A2 BR112014019504 A2 BR 112014019504A2 BR 112014019504 A BR112014019504 A BR 112014019504A BR 112014019504 A BR112014019504 A BR 112014019504A BR 112014019504 A2 BR112014019504 A2 BR 112014019504A2
Authority
BR
Brazil
Prior art keywords
grassland
methods
immune response
allergens
individual
Prior art date
Application number
BR112014019504A
Other languages
English (en)
Inventor
Sette Alessandro
Peters Bjoern
Grey Howard
Greenbaum Jason
Schulten Veronique
Original Assignee
La Jolla Inst Allergy & Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Jolla Inst Allergy & Immunology filed Critical La Jolla Inst Allergy & Immunology
Publication of BR112014019504A2 publication Critical patent/BR112014019504A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo patente de invenção: "alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune". a presente invenção refere-se a proteínas e peptídeos da erva-dos-prados, subsequências, porções, homólogos, variantes e derivados dos mesmos, e métodos e usos de proteínas e peptídeos da erva-dos-prados. os métodos incluem, por exemplo, modular uma resposta imune; proteger um indivíduo ou tratar um indivíduo para uma resposta alérgica, distúrbio alérgico ou doença alérgica; e induzir tolerância imunológica ao alérgeno em um indivíduo.
BR112014019504A 2012-02-07 2013-02-07 alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune BR112014019504A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
BR112014019504A2 true BR112014019504A2 (pt) 2017-06-27

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014019504A BR112014019504A2 (pt) 2012-02-07 2013-02-07 alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune

Country Status (13)

Country Link
US (1) US10428124B2 (pt)
EP (1) EP2812026A4 (pt)
JP (1) JP2015513527A (pt)
KR (1) KR20140129124A (pt)
CN (1) CN104203277A (pt)
AU (1) AU2013216993C1 (pt)
BR (1) BR112014019504A2 (pt)
CA (1) CA2864084A1 (pt)
EA (1) EA201491481A1 (pt)
HK (1) HK1204929A1 (pt)
IN (1) IN2014MN01513A (pt)
MX (1) MX2014009285A (pt)
WO (1) WO2013119863A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
EA201691028A1 (ru) 2013-11-20 2017-01-30 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа
KR20160096206A (ko) 2013-12-23 2016-08-12 알크-아벨로 에이/에스 먼지 진드기 알레르기를 치료하기 위한 펩타이드 조합 및 그의 용도
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
AU2015329070B2 (en) 2014-10-07 2018-11-22 Nec Corporation Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
WO2016143816A1 (ja) 2015-03-09 2016-09-15 日本電気株式会社 Ｇｐｃ３由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
RU2709015C2 (ru) 2015-04-07 2019-12-13 Ситлимик Инк. Лекарственное средство
AU2017342189B2 (en) 2016-10-11 2023-09-21 Nec Corporation Medicine
JP7184259B2 (ja) * 2017-04-28 2022-12-06 学校法人藤田学園 アレルギーの抗原およびそのエピトープ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
EP2392591B1 (de) 2002-06-25 2018-02-21 Merck Patent GmbH DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Phl p 4
BRPI0313613B1 (pt) * 2002-08-19 2016-06-07 Merck Patent Ges Mit Beschränkter Haftung variantes do principal alérgeno phl p 1 de capim-timóteo, suas formas de enovelamento lm e hm, seus usos e seus processos de preparação e de purificação, molécula de dna, vetor de expressão de dna recombinante e seu uso, e composições farmacêuticas
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
EP1850656A4 (en) 2005-01-12 2010-04-07 Monsanto Technology Llc GENES AND ITS USES FOR THE PLANT PROCESSING OF PLANTS
EP3097927B1 (en) * 2008-02-01 2023-05-03 Murdoch Childrens Research Institute A method of inducing tolerance to an allergen
EP2388268A1 (en) 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
WO2012049312A1 (en) 2010-10-15 2012-04-19 Alk-Abelló A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
EP2627355B1 (en) 2010-10-15 2015-08-26 ALK-Abelló A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
EP2831102A4 (en) * 2012-03-26 2015-12-02 Pronutria Inc NUTRIENT FRAGMENTS, NUTRIENT PROTEINS AND METHODS
AU2013248275B2 (en) 2012-04-16 2017-03-30 Alk-Abello A/S Plant profilin polypeptides for use in non-specific allergy immunotherapy

Also Published As

Publication number Publication date
US20150023992A1 (en) 2015-01-22
HK1204929A1 (en) 2015-12-11
CA2864084A1 (en) 2013-08-15
AU2013216993A1 (en) 2014-08-21
EP2812026A4 (en) 2016-04-27
MX2014009285A (es) 2015-02-04
EA201491481A1 (ru) 2014-11-28
EP2812026A1 (en) 2014-12-17
US10428124B2 (en) 2019-10-01
JP2015513527A (ja) 2015-05-14
AU2013216993C1 (en) 2017-01-19
WO2013119863A1 (en) 2013-08-15
AU2013216993B2 (en) 2016-09-15
CN104203277A (zh) 2014-12-10
KR20140129124A (ko) 2014-11-06
IN2014MN01513A (pt) 2015-09-11

Similar Documents

Publication Publication Date Title
BR112014019504A2 (pt) alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune
BR112017009807A2 (pt) métodos e formulações para tratamento de doenças oculares vasculares
BR112013007314A2 (pt) anticorpos anti-cd48 e seus usos
BR112014027571A2 (pt) métodos para o tratamento de retinopatia diabética e outras doenças oftalmológicas
BR112015003590A8 (pt) Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
BR112015000150A2 (pt) composições farmacêuticas dissuasoras de abuso de liberação controlada
BR112016022499A2 (pt) Produtos terapêuticos combinatórios supramoleculares
BR112016010166A2 (pt) métodos para usar interleucina-10 para tratar doenças e distúrbios
UY35195A (es) Composiciones y metodos para proteinas de accion prolongada
BR112015011171A2 (pt) compostos de pirrolopirimidina como inibidores da quinase
BR112012027055A8 (pt) agente estabilizante para proteínas farmacêuticas.
BR112014023800A2 (pt) moléculas de ácidos nucleicos artificiais
BR112015012536A2 (pt) tratamento de câncer com inibidores heterocíclicos da glutaminase
BR112014031327A2 (pt) ácidos nucleicos para o tratamento de alergias
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
BR112015005117A2 (pt) métodos de tratamento da doença de alzheimer e suas composições farmacêuticas
BR112015000776A2 (pt) Agentes de ligação à rspo3 e usos dos mesmos
BR112015001847A2 (pt) composições e tratamento para doenças e distúrbios nos olhos
BR112014012808A2 (pt) proteína de fusão anticâncer
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
BR112014019776A2 (pt) composições e métodos para o tratamento de doença vascular periférica
WO2014204816A3 (en) Method for assessing protein identity and stability
BR112015017775A2 (pt) enzima cistationina beta-sintase para o tratamento de homocistinúria
BR112016030172A2 (pt) aptâmeros específicos para tlr-4 e usos dos mesmos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2500 DE 04-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.